tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Galmed Pharmaceuticals (GLMD)
NASDAQ:GLMD
US Market
GLMD
Galmed Pharmaceuticals
RESEARCH TOOLSreports
Advertisement

Galmed Pharmaceuticals (GLMD) Stock News & Sentiment

Compare
1,306 Followers
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
Premium
Company Announcements
Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
3h ago
6K
GLMD
Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
Premium
Company Announcements
Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
3d ago
6K
GLMD
Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs
Premium
Company Announcements
Galmed Pharmaceuticals Reports Q3 2025 Financials and Research Breakthroughs
8d ago
6K
GLMD
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
Premium
Company Announcements
Galmed Pharmaceuticals Reports Promising Results from Aramchol Meglumine Study
16d ago
6K
GLMD
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study
Premium
Company Announcements
Galmed Pharmaceuticals Reveals Promising Results in Oncology Drug Combination Study
17d ago
6K
GLMD
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting
Premium
Company Announcements
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting
1M ago
6K
GLMD
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum
Premium
Company Announcements
Galmed Pharmaceuticals Reschedules Annual General Meeting Due to Lack of Quorum
1M ago
6K
GLMD
More GLMD News >

GLMD News on the Web

Galmed Pharmaceuticals Secures New Patent for Aramchol Combination Therapy
TipRanks News
Neutral
Galmed Pharmaceuticals Expands Aramchol’s Clinical Applications and Strengthens Financial Position
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Cartesian Therapeutics (RNAC) and Galmed Pharmaceuticals (GLMD)
TipRanks News
Neutral
Galmed Pharmaceuticals Unveils Potent Anti-Tumor Drug Synergy, Eyes Early-2026 Phase 1b Trial
Market Chameleon
Neutral
Galmed’s 3-Drug Combination Shows Enhanced Tumor Cell Killing: What the New Study Means for GI Cancer and the Future of Stivarga
Market Chameleon
Neutral
Galmed Pharmaceuticals Unveils Digital Asset Strategy and Modifies SEDDS Agreement
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Entrada Therapeutics Inc (TRDA), Galmed Pharmaceuticals (GLMD) and Xilio Therapeutics (XLO)
TipRanks News
Neutral
Galmed Pharmaceuticals Unveils Promising Oncology Study Results with Aramchol
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
GLMD
Sector Average
Media Buzz
This Week1 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average55%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is GLMD’s Media Buzz Sentiment?
1 articles about GLMD were published this week. In an average week, 1 articles are published.
    What is GLMD’s weekly average amount of articles?
    In an average week, 1 articles about GLMD are published.
      What is GLMD’s News Sentiment?
      50% of articles about GLMD were positive this week, compared to its sector average of 55%.
        Healthcare Stocks that are Trending in the News
        PHGKoninklijke Philips
        ACHCAcadia Healthcare
        PXSParagon Care Limited
        CRMDCormedix
        IDXXIdexx Laboratories
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing